Transplants can be life-saving – but for many, the journey doesn’t end there. Up to 40% of people receiving a stem cell or bone marrow transplant will go on to develop a serious complication known as ...

The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.

The pressure comes on top of a project to cut medicine prices in the United States to align them with the lowest rates elsewhere.

Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...

The visit spotlighted the emirate’s achievements in AI, digital health, genomics, and clinical research, and showcased Abu ...

Merck & Co. agreed to buy respiratory drugmaker Verona Pharma Plc for around $10 billion as part of its ongoing search for ...

The annual Small Business Equity Tracker from the UK Government’s economic development bank shows that Wales was only one of ...

Leerink Partners called the announcement a ‘positive’ given the delayed timeframe and the uncertainty that the administration ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

US clinical-stage biotech ProKidney reported statistically-significant and clinically-meaningful positive top-line results ...

A GLP-1/glucagon dual agonist conferred weight loss of up to 12.55% at 32 weeks for adults with overweight or obesity, ...

ExodusPoint burst onto the hedge fund scene in 2018 with the largest launch in history — raising $8.5 billion out of the gate — powered by institutional backing, an elite Wall Street pedigree, and ...